Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Why Economic Indices Matter explains how these measurements influence asset allocation and risk controls, helping you make smarter financial decisions.
21,763 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
As lawmakers push hundreds of AI bills, a lack of universal testing leaves companies and investors facing a maze of r...
Ready to invest $10,000 in energy? This guide argues for a top-tier, cash-flow-driven pick and shows you how to maxim...
New long-term care products now let many baby boomers access coverage without underwriting, signaling a shift in reti...
Intel stock climbs about 5% after word that the company is in talks to acquire AI accelerator startup Tenstorrent, re...
IMAX bucked trend as cinema operators fade; investors eye the premium-format chain's sale.
Income-focused investors flock to AGNC for its big dividend, but the real driver of long-term value is its net intere...
As investors seek durable AI upside beyond chips, three ETFs focusing on the software layer beat peers and promise re...
Inflation pushes per-date costs toward $200, nudging Gen Z and millennials toward solo maxxing and away from traditio...
Investors are buzzing as SAIC reports stronger-than-expected results and a growing federal pipeline. This article bre...
A fresh look at a chilling historical echo: the 1987 omen: kevin warsh's. As markets brace for a new Fed chair, inves...
NVIDIA has moved beyond gaming GPUs to become a cornerstone of the AI era. This shift, described by some as NVIDIA ju...